Renaissance Capital logo

Five Prime Therapeutics Priced, Nasdaq: FPRX

Developing protein therapeutics for cancers and autoimmune diseases.

Industry: Health Care

First Day Return: +0.6%

Industry: Health Care

Developing protein therapeutics for cancers and autoimmune diseases.
more less
IPO Data
IPO File Date 07/26/2013
Offer Price $13.00
Price Range $12.00 - $14.00
Offer Shares (mm) 4.8
Deal Size ($mm) $62
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 09/17/2013
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $62
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters South San Francisco, CA, United States
Founded 2001
Employees at IPO 108
Website www.fiveprime.com

Five Prime Therapeutics (FPRX) Performance